Menu

Yassine DARBAKY

CLERMONT-FERRAND

En résumé

Dr. Yassine Darbaky is the head of the in vivo Pharmacology Laboratory at ANS Biotech®.
He holds a Ph.D. in Neurosciences obtained in 2004.
Regarding his behavioral background, he had the opportunity to obtain a Postdoctoral position in Sanofi-aventis® in Paris where he was in charge of the set up and development of new models of chemo-induced neuropathies in rodents.
Then, he continued to develop his expertise in pain pharmacology when he reached a biotech company in south of France called Neorphys®. He stayed during one year in this company specialized in new opioïd analgesics as Neuropharmacologist before joining ANS Biotech® in July 2007.
At ANS Biotech®, he manages a technical team, he is study director for fee for services and he is in charge of R&D projects such as cancer pain or neuropathic pain.

Mes compétences :
Qualité
Gestion de projet
R&D
Industrie pharmaceutique

Entreprises

  • ANS Biotech - Pharmacology Lab Director at ANS Biotech

    2007 - maintenant ANS Biotech is a privately held, independent preclinical Contract Research Organization dedicated to developing clinically relevant disease and efficacy models focused on pain pharmacology.
    The company offers his customers a unique combination of an extensive and innovative expertise in fundamental pharmacology of pain as well as a strong background in Research & Development (R&D) for new analgesics.
    ANS Biotech mission is to support drug discovery and development efforts of companies involved in human and animal health, food and nutrition, by providing them with additional capabilities in preclinical pain research.
    As an expert partner, ANS Biotech commits to providing his clients with:
    • Relevant selection of preclinical pharmacology services for successful R&D of innovative analgesics: in vivo experiments & proof of concept studies, mechanism of action studies, therapeutic positioning, consulting
    • Customized scientific studies (fee for services activities and collaborations) meeting drug discovery and development objectives
    • Access to clinical pharmacology capabilities in pain and analgesia research (Clinical Investigation Center)
    ANS Biotech is a Young Innovative Company (YIC status) and has a French agreement for Research Tax Credit.

  • Neorphys - Neuropharmacologist

    2006 - 2007 Neorphys™ is a biopharmaceutical company which discovers and develops novel lifestyle drug candidates with a particular focus on female desire dysfunction and nausea-free acute pain management.

    Subject: Preclinical development of candidates for nausea-free acute pain management (Neorphine™) and female desire dysfunctions (Neoxytine™)

  • Sanofi-aventis - Post-Doctoral position (neurological diseases)

    Paris 2004 - 2006 Sanofi-Aventis (Euronext: SAN, NYSE: SNY) is one of the five largest pharmaceutical companies in the world. Sanofi-Aventis engages in the research, development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market. Sanofi-Aventis cover 7 major therapeutic areas: cardiovascular, thrombosis, oncology, diabetes, central nervous system, internal medicine and vaccines (with its subsidiary Sanofi-Pasteur).

    Subject: Development of chemotherapy-induced neuropathies rodent models

Formations

  • Université Aix Marseille 2 Mediterranée (Marseille)

    Marseille 1997 - 2004 Doctorat Neurosciences

    Ecole Doctorale des Sciences de la Vie et de la Santé

    Laboratory of Functional and Cellular Neurobiology (director: Pr. A. Nieoullon)
    Functional effects of electrical high frequency stimulation of the subthalamic nucleus in experimental models of Parkison’s disease
    Supervisor: Dr. C. Baunez

Réseau

Annuaire des membres :